Skip to main content

Highlights

  1. 1
    Clinical chemistry · 2020
    PMID: 32821907PMCID: PMC7499540DOIFirst author97 citations
  2. 2
    JAMA network open · 2021
    PMID: 33749770PMCID: PMC7985726DOIFirst author171 citations
  3. 3
    Clinical chemistry · 2023
    PMID: 37738611DOIFirst author21 citations

Publications

78 publications

Funding

3 grants

Active

2 grants
  • Co-I
    Development of An Integrated Pipeline for Early PD Prediction and Disease Modifying Drug Repurposing
    National Institute of Neurological Disorders and Stroke · 2026–2031
    R01NS148533-01
  • PI
    Analytical and Clinical Performance of the LIAISON® MeMed BV® (DiaSorin SRA)
    DiaSorin SpA · 2024–2027Contract
    SRA 235192-01
Completed grants (1)
  • Co-I
    Laboratory Service Agreement with NPC
    Novartis Pharmaceuticals Corporation · 2021–2022Contract
    NPC 211486-01

Clinical research

2 studies

Active

2 studies
  • PI
    From data to diagnostics: advanced data analysis of sexually transmitted infection (STI) diseases with biomarker discovery
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2026)
  • PI
    Assessing the analytical and clinical performance of the LIAISON MeMed BV test in differentiating bacterial from viral infections
    Weill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)

News mentions

  • AI System May Help Clinical Labs Spot Problems Before They Affect Patients
    November 2, 2026

    Weill Cornell Medicine researchers have designed an AI system that could help clinical laboratories identify problems before they disrupt testing and delay patient care. These laboratories analyze samples such as blood, urine, tissue or other bodily fluids to help doctors diagnose and treat diseases. However, growing test volumes, workforce shortages and increasingly complex diagnostics are placing mounting demands on laboratory operations. In a perspective published Oct. 28 in npj Health Systems, the researchers describe Laboratory Agentic Reasoning and Integrative Analytics (LabARIA), one of the first frameworks using several specialized AI tools called agents to help monitor laboratory quality and operations more efficiently. Dr. Fei Wang “Laboratory medicine is a critical but largely neglected area, especially considering the AI work already done in radiology and pathology,” said senior author Dr. Fei Wang, associate dean for artificial intelligence and the Frances and John Loeb Professor of Medical Informatics in the Department of Population Health Sciences at Weill Cornell. Existing AI algorithms developed for laboratory medicine are fragmented and largely confined to task-specific silos, the authors write. LabARIA is designed to integrate these capabilities, allowing the system to identify patterns across different aspects of laboratory operations that individual tools might miss. The proposed framework would connect to existing laboratory information systems and other databases rather than replace them. A central AI “data coordinator” would route information to specialized AI agents that monitor specimen quality, testing turnaround times, analytical quality control, instrument performance and regulatory compliance. Other agents would forecast inventory and staffing needs. Dr. He Sarina Yang “This framework can identify anomalies and pull data together to help lab personnel investigate and address problems earlier,” said lead author Dr. He Sarina Yang,…

  • In Brief: Machine Learning Tool Predicts SARS-CoV-2 Infection Using Routine Blood Test Results
    October 26, 2020

    Weill Cornell Medicine and NewYork-Presbyterian investigators have built a machine-learning tool that can predict SARS-CoV-2 infection based on age, gender, race and 27 routine laboratory test results.